Hussman Strategic Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

Hussman Strategic Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$39.92 - $53.86 $399,200 - $538,600	-10,000 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$55.63 - $73.24 $834,450 - $1.1 Million	-15,000 Reduced 60.0%	10,000 $593,000
Q3 2018 Oct 31, 2018	BUY	$52.05 - $66.51 $1.3 Million - $1.66 Million	25,000 New	25,000 $1.65 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $414M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.